Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Long-term Investment Intensity
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Long-term Investment Intensity of 12.2% as of September 2019. Long-term investments of CN¥605.54 Million represent 12.2% of total assets of CN¥4.95 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 600645 net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Vcanbio Cell & Gene Engineering Corp Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Vcanbio Cell & Gene Engineering Corp Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 12.2%, reflecting long-term investments of CN¥605.54 Million against total assets of CN¥4.95 Billion CNY. Also explore Vcanbio Cell & Gene Engineering Corp Ltd asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Vcanbio Cell & Gene Engineering Corp Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Vcanbio Cell & Gene Engineering Corp Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600645 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 12.6% | CN¥562.09 Million | CN¥4.44 Billion | ▼ -3.3 pp |
| 2017 | 16.0% | CN¥479.03 Million | CN¥3.00 Billion | ▲ +3.0 pp |
| 2016 | 12.9% | CN¥388.88 Million | CN¥3.00 Billion | ▼ -0.7 pp |
| 2015 | 13.6% | CN¥383.19 Million | CN¥2.82 Billion | — |